{"id":"W4406268174","doi":"10.1016/j.esmoop.2024.104107","title":"Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre","funders":"Ono Pharmaceutical; National Cancer Institute; Celgene; Agilent Technologies; Bristol-Myers Squibb","keywords":"Gastroesophageal Junction; Medicine; Cancer; Internal medicine; Nivolumab; Gastroenterology; Oncology; Adenocarcinoma; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002323419,0.0001556934,0.0002432081,0.0002259695,0.0002843255,0.00006349149,0.0001299775,0.00003831606,0.0001477879],"category_scores_gemma":[0.00001000069,0.0001026641,0.00002452659,0.0008810322,0.00006177418,0.0003116555,0.00006860543,0.0001906831,5.425603e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003675886,"about_ca_system_score_gemma":0.0001712745,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006767867,"about_ca_topic_score_gemma":0.002846011,"domain_scores_codex":[0.9989931,0.00008913303,0.0002267848,0.0002857155,0.0002185031,0.0001867639],"domain_scores_gemma":[0.9994971,0.00002880985,0.000133726,0.0002107861,0.00009860656,0.00003100944],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01029738,0.001581066,0.5897164,0.00001217175,0.0001808189,0.000002181173,0.000464102,0.00001884469,0.00008772445,0.000004764893,0.0004365814,0.397198],"study_design_scores_gemma":[0.0349376,0.004253862,0.9576125,0.0001559499,0.0001149653,0.00000133515,0.0008725893,0.00008803625,0.0001017614,0.00001304706,0.001766636,0.00008176709],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950441,0.0007108507,0.0001033061,0.001010782,0.0002685176,0.002571221,0.000009520501,0.00002056682,0.0002611885],"genre_scores_gemma":[0.9977713,0.0003803532,0.00006041624,0.0003965552,0.00002821607,0.0005297867,0.00002853686,0.00001375569,0.0007911176],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3971162,"threshold_uncertainty_score":0.9998462,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009857846797699509,"score_gpt":0.3101867163670241,"score_spread":0.3003288695693245,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}